Not for everyone, but for certain cancers it genuinely matters. Genetic testing looks for inherited gene changes, like BRCA in breast and ovarian cancer, that can change how much tissue a surgeon should remove and whether the other side needs attention too. For most cancers it isn’t required, yet where a known gene is involved, the result can reshape the whole surgical plan. That’s why it’s considered case by case.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “When a patient carries a gene like BRCA, I plan the surgery differently, sometimes far more extensively, so I’d rather know before I operate than discover it afterwards.”

It isn’t routine for every patient, but in some situations it really earns its place. Here’s when.

• A strong family history: Several close relatives with the same cancer is a red flag that an inherited gene may be in play, and that’s worth checking first.
• Young at diagnosis: Cancer showing up unusually early often points to a genetic cause, which can change how the surgery is approached.
• Specific cancers: Breast, ovarian and colorectal cancers have well-known gene links, so testing here can directly affect the operation chosen.
• It changes the plan: If a result would mean removing more tissue or operating on both sides, knowing beforehand beats finding out later.

So testing first is about operating with the full picture. Much like what an IHC test adds at the cell level, a gene result fills in detail the surgeon needs before deciding.

When a gene shows up, it can shift the plan in real, practical ways. These are the main ones.

• Wider removal: A BRCA result in breast cancer, for instance, may steer a patient toward removing more tissue rather than a smaller operation.
• Both sides considered: Some inherited risks raise the odds for the other breast or ovary, so surgery may be planned to cover both.
• Timing other organs: A strong gene result sometimes brings forward preventive surgery on organs not yet affected.
• Family gets warning: A positive result flags risk for close relatives too, letting them screen early long before anything shows.

So the gene doesn’t just inform your surgery, it can protect your family. For suitable cases, robotic cancer surgery then carries out that tailored plan with precision.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to surgery across all cancer types. He factors genetic results into the surgical plan from the start, rather than treating them as an afterthought once the operation is already decided.

That forward planning is what makes a surgery fit the patient, not just the tumour. Every case at MACS Clinic goes through a full tumour board, where genetics, pathology and imaging are weighed together before anything is confirmed. Call +91 8104310753 to book your consultation.

References:

1. National Cancer Institute — Genetic Testing for Cancer. https://www.cancer.gov/
2. World Health Organisation — Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer

Whether chemotherapy comes first (neoadjuvant) or surgery comes first (adjuvant) depends entirely on the tumour size, cancer type and stage. A multidisciplinary tumour board makes this call, weighing how best to achieve a complete cure, shrink the tumour to allow less invasive surgery, or lower the risk of the cancer coming back. So the order is picked to fit your case, not by some fixed rule.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “I’d never decide the order alone or out of habit, because for some cancers chemo first changes what surgery can actually achieve, and getting that sequence right matters as much as the operation itself.”

Sometimes it makes more sense to treat the body before touching the tumour. Here’s when.

• To shrink it down: A big or awkwardly placed tumour often softens up with chemo first, which makes it smaller and a lot easier to take out cleanly.
• To catch hidden spread: If there’s a real chance stray cells have slipped out, chemo upfront goes after them before surgery handles the main lump.
• To see how it responds: Chemo first shows how the tumour reacts to the drugs, and that tells the team what to do after the operation.
• Certain cancers: Breast, rectal and some stomach cancers just do better with chemo leading, because that’s what the evidence keeps showing.

So chemo first isn’t a delay, it’s a plan. Working out the right order for your case is exactly why a second opinion before treatment is worth it.

Other times you just take the tumour out and get on with it. These are those cases.

• It’s clearly removable: When the tumour is contained and operable as it stands, there’s no real reason to wait, so surgery goes first.
• You need the full pathology: Removing it first gives the complete read on type and grade, and that shapes whatever chemo follows.
• Chemo won’t help yet: Some cancers simply don’t shrink with chemo, so holding back surgery for it would gain nothing.
• It can’t wait: A tumour blocking, bleeding or pressing on something usually has to come out first, whatever the long game looks like.

So surgery first is about acting when waiting buys you nothing. In the right cases, robotic cancer surgery takes the tumour out precisely and gets recovery moving sooner.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to every treatment decision across all cancer types. He weighs the order of treatment on the evidence and your specific case, rather than defaulting to whichever step is quickest.

That careful sequencing is what gives a treatment plan its best chance. Every case at MACS Clinic goes through a full tumour board, where surgery, chemotherapy and radiation are weighed together before the order is set. Call +91 8104310753 to book your consultation.

References:

1. National Cancer Institute — Types of Cancer Treatment. https://www.cancer.gov/
2. World Health Organisation — Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer

Stage 2 cancer is both treatable and, in most cases, curable. The tumour has grown a little or reached nearby lymph nodes, but it hasn’t spread to distant organs, and that’s what keeps the chance of a full cure high. Treatment usually means surgery, sometimes with chemo or radiation added. How it plays out still depends on the exact cancer.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “Stage 2 is where I’m genuinely aiming for a cure in most cases, not just control, but the word covers very different cancers, so the number alone never tells the whole story for a patient.”

The number tells you how far things have gone, not how bad they have to turn out.

• It’s grown a bit: Bigger than stage 1, or into nearby tissue, but still sitting in or around where it first started.
• A few nodes, maybe: Some close lymph nodes can be involved. That’s not the same thing as the cancer reaching distant organs.
• Nothing far off: The key point is that it hasn’t travelled across the body, and that’s what keeps a cure well within reach.
• Depends on the cancer: Stage 2 in the breast and stage 2 in the stomach are different battles, so the label shifts meaning by site.

So stage 2 sits squarely in treatable, often curable, territory. Pinning down exactly where you stand is why a second opinion here is worth the time.

The aim is to cure it, and surgery normally leads the way.

• Surgery up front: For most solid stage 2 cancers, taking the tumour out is the main move, and often it’s all that’s needed.
• Chemo if needed: Some people have chemo afterwards to mop up stray cells and cut the odds of it returning.
• Radiation sometimes: In breast or rectal cancers especially, targeted radiation may follow to cover the area properly.
• The board decides: What gets combined is worked out case by case, going on cancer type, your health and what the scans show.

So the whole plan is built to beat it, not just keep it in check. In suitable cases, robotic cancer surgery takes the tumour out precisely and gets people home sooner.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to the treatment of every stage and type of cancer. He explains plainly what a stage 2 diagnosis means for the chance of cure, rather than leaving patients to fear the number alone.

That honest framing is what turns a frightening label into a clear plan. Every case at MACS Clinic goes through a full tumour board, where pathology, imaging and oncology weigh in together before anything is confirmed. Call +91 8104310753 to book your consultation.

References:

1. National Cancer Institute — Cancer Staging. https://www.cancer.gov/
2. World Health Organisation — Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer

In most cases, yes, health insurance does cover robotic surgery. What insurers pay for is the operation itself when it’s medically necessary, not the tool used to perform it, so a robotic procedure is usually treated like any other cancer surgery. The catch is that some policies cap the payout, and where the robotic cost runs higher, you may cover the gap. The safe step is to confirm it in writing before surgery.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “Insurance almost always covers the cancer surgery, but patients get caught out by sub-limits, so I tell them to get written pre-authorisation rather than assume the robotic part is fully covered.”

It comes down to a few things in the fine print, not the technology itself.

• Medical necessity: When the surgery is needed to treat cancer, the procedure is covered, and the robotic method generally falls under that same approval.
• Your policy limits: Some plans set a ceiling on surgical payouts, and if the robotic cost sits above it, the difference lands on you.
• The hospital tie-up: Cashless cover works only where your insurer has an agreement with the hospital, otherwise you claim it back later.
• Sub-limits and clauses: Room rent caps and procedure-specific limits quietly reduce what’s paid, which is exactly where people get surprised.

So the answer lives in the details of your plan. Anyone weighing the surgery cost of a robotic procedure should read those clauses before deciding.

A little paperwork upfront saves a lot of trouble later.

• Get pre-authorisation: Ask your insurer for written approval before surgery, so there’s no argument about coverage afterward.
• Read the sub-limits: Look specifically for caps on surgery, room rent and consumables, since these decide your real out-of-pocket cost.
• Use the insurance desk: Most hospitals have a team that handles claims and pre-authorisation directly, so lean on them.
• Keep every document: Reports, bills, discharge summary, all of it. A clean paper trail is what gets a claim approved without delay.

So coverage is as much about preparation as the policy itself. For patients considering robotic cancer surgery, sorting the insurance early removes one big worry from an already heavy time.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to robotic cancer surgery across all cancer types. His team helps patients understand the cost and insurance side clearly, so there are no nasty surprises once treatment is underway.

That transparency is what lets patients focus on getting well, not on paperwork. Every case at MACS Clinic goes through a full tumour board, where pathology, imaging and oncology weigh in together before anything is confirmed. Call +91 8104310753 to book your consultation.

References:

1. National Cancer Institute — Managing Cancer Care Costs. https://www.cancer.gov/
2. World Health Organisation — Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer

you can absolutely work during cancer treatment. Many people continue working full-time or part-time, as it provides a sense of routine, normalcy, and financial security. Your ability to work depends heavily on your specific treatment plan, the side effects you experience, and the physical demands of your job. 

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “I encourage patients to hold on to what they can of normal life, work included, but I’m just as clear that treatment comes first, and pushing through genuine fatigue helps no one.”

A handful of practical things settle this, and willpower is only one small part.

• The treatment: Surgery needs recovery time. Chemo and radiation bring tiredness in waves, and that’s what makes a full week hard to hold together.
• Your kind of job: Sitting at a desk is far easier to sustain than heavy physical work, which can be too much in the middle of treatment.
• How you feel: Energy rises and falls without much warning. Good days happen, rough ones happen, and neither is a sign of anything wrong.
• Your workplace: Where an employer offers flexible hours or a lighter load, staying on becomes realistic instead of exhausting.

So much of it is about whether the pieces fit. People planning treatment around their lives often find a second opinion helps set honest expectations.

Small, sensible adjustments tend to make the biggest difference here.

• Speak to your employer: Raise it early. That way flexible timing or work-from-home days are in place before you actually lean on them.
• Time your sessions: A lot of people book treatment for a Friday, letting the worst couple of days pass over the weekend.
• Guard your rest: Sleep and recovery aren’t luxuries to trade away. They’re the thing that lets you turn up at all, so protect them.
• Lean on help: Lighter duties, shorter days, a hand from colleagues. None of that is falling short. It’s just how sensible people get through.

So it’s really about adjusting rather than gritting your teeth. For anyone weighing robotic cancer surgery, the quicker recovery can also mean an earlier, smoother return to work.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to every treatment plan across all cancer types. He talks through the everyday side of treatment, work included, rather than treating recovery as something walled off from the rest of life.

That down-to-earth approach is what helps patients stay themselves through it. Every case at MACS Clinic goes through a full tumour board, where pathology, imaging and oncology weigh in together before anything is confirmed. Call +91 8104310753 to book your consultation.

References:

1. National Cancer Institute — Working During Cancer Treatment. https://www.cancer.gov/
2. World Health Organisation — Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer